TALPHERA, INC. — Director's Dealing 2014

Feb 4, 2014

SEC Form 4/A — Form 4/A

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2014-01-17

Reporting Person: Hamel Lawrence G (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-17	Common Stock	A	5283	$1.20	Acquired	44002	Direct
2014-01-17	Common Stock	D	1000	$12.74	Disposed	43002	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-17	Stock Option (Right to Buy)	$1.20	D	5283	Disposed	2017-04-03	Common Stock (5283)	Direct

Footnotes

F1: The sale is pursuant to the reporting person's 10b-5 Plan.

F2: The shares subject to the option vest as follows: 1/4 of the shares subject to the option vest on September 20, 2007 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months.